ZRSR2 is one of the top synthetic lethal hits in our genome-wide EXO1 KO CRISPR screen, and its mutations and deletions represent a significant cancer vulnerability, with frequent driver mutations in cancers of hematopoietic origin41. Here, ZRSR2 is linked to cancer.